Annual Report 2020

133 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 綜合財務報表附註 FOR THE YEAR ENDED 31ST DECEMBER, 2020 截至二零二零年十二月三十一日止年度 ANNUAL REPORT 2020 年度報告 25. 以股份支付之支出 （續） 股權支付交易購股權計劃 （續） 未經本公司股東根據該計劃事先批准，向任何個人 可能授出之購股權涉及之股份數目，於任何十二個 月期間，均不得超過本公司於任何時間已發行股份 之 1% 。倘向一名主要股東或獨立非執行董事或任 何彼等各自之聯繫人士授出任何購股權，會導致 因授予該人士之所有購股權獲行使而於截至授出日 期（包括當日）止十二個月期間，已經及將予以發 行之本公司股份，合共佔本公司已發行股份超過 0.1% ，且價值（根據本公司股份於每次授出購股權 日期之收市價計算）超過 5,000,000 港元，則根據該 計劃該項授出購股權須事先得到本公司股東批准。 購股權可於董事釐定及知會承授人之期間內隨時行 使，倘未有釐定，則由接納授出購股權日期起至該 購股權失效之日或授出該購股權日期起計十年之較 早日期。於接納購股權時須付 1 港元代價。 行使價乃由本公司董事釐定，惟不得低於股份面 值、本公司股份於授出日期之收市價及股份緊接授 出日期前五個營業日之平均收市價之較高者。 25. SHARE-BASED PAYMENTS (Continued) Equity-settled share option scheme (Continued) The number of shares in respect of which options may be granted to any individual in any 12-month period is not permitted to exceed 1% of the shares of the Company in issue at any point in time, without prior approval from the Company’s shareholders in accordance with the Scheme. Where any grant of options to a substantial shareholder or an independent non-executive director or any of their respective associates would result in the shares in the Company issued and to be issued upon exercise of all options to such person in the 12-month period up to and including the date of grant in excess of 0.1% of the shares of the Company in issue and with a value (based on the closing price of the shares of the Company at the offer date of each offer) in excess of HK$5,000,000, such grant of options must be approved in advance by the Company’s shareholders in accordance with the Scheme. An option may be exercised at any time during the period to be determined and notified by the directors to the grantee and in the absence of such determination, from the date of acceptance of an offer of the grant of such option to the earlier of the date on which such option lapses and ten years from the date of offer of that option. A consideration of HK$1 is payable upon acceptance of the offer. The exercise price is determined by the directors of the Company, and will not be less than the higher of the nominal value of the share; the closing price of the Company’s shares on the date of offer; and the average closing price of the shares for the five business days immediately preceding the date of offer.